Royalty Pharma Plc Cl A (RPRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | RPRX | BIIB | BNTX | ||
| Company | Royalty Pharma Plc Cl A | Biogen Inc | Biontech Se ADR | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 46.81 | 179.46 | 86.29 | ||
| High | 47.76 | 181.50 | 88.56 | ||
| Low | 46.68 | 171.37 | 86.29 | ||
| Latest | 47.54 | 181.14 | 88.28 | ||
| Change | +1.17 | -6.43 | +3.03 | ||
| % Change | +2.52% | -3.43% | +3.55% | ||
| Volume | 983,490 | 1,469,282 | 340,945 | ||
| 20-Day Average Volume | 3,286,114 | 937,641 | 1,794,551 | ||
| Previous Close | 46.37 | 187.57 | 85.25 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 46.14 | 185.55 | 91.46 | ||
| 20-Day Raw Stochastic | 88.18% | 34.48% | 31.92% | ||
| 20-Day Relative Strength | 64.00 | 45.59 | 39.39 | ||
| Weighted Alpha | +55.00 | +43.31 | -10.99 | ||
| Today's Opinion | 100% Buy | 56% Buy | 72% Sell | ||
| Previous Opinion | 100% Buy | 96% Buy | 72% Sell | ||
| Last Month's Opinion | 100% Buy | 88% Buy | 72% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +4.21% since 03/24/26 | -2.33% since 03/24/26 | +0.63% since 03/24/26 | ||
| Low | 45.79 on 03/25/26 | 172.65 on 03/31/26 | 84.78 on 03/30/26 | ||
| High | 47.65 on 03/31/26 | 192.27 on 03/26/26 | 89.33 on 03/26/26 | ||
| 1-Month | |||||
| %Chg | +2.77% since 02/27/26 | -6.34% since 02/27/26 | -20.75% since 02/27/26 | ||
| Low | 44.73 on 03/20/26 | 172.65 on 03/31/26 | 79.52 on 03/10/26 | ||
| High | 47.86 on 03/04/26 | 192.99 on 03/11/26 | 110.10 on 03/02/26 | ||
| 3-Month | |||||
| %Chg | +21.09% since 12/26/25 | +1.46% since 12/26/25 | -7.58% since 12/26/25 | ||
| Low | 38.29 on 01/02/26 | 160.36 on 01/20/26 | 79.52 on 03/10/26 | ||
| High | 47.86 on 03/04/26 | 202.41 on 02/06/26 | 124.00 on 01/22/26 | ||
| 6-Month | |||||
| %Chg | +35.53% since 09/26/25 | +30.79% since 09/26/25 | -10.93% since 09/26/25 | ||
| Low | 34.79 on 09/29/25 | 135.39 on 09/29/25 | 79.52 on 03/10/26 | ||
| High | 47.86 on 03/04/26 | 202.41 on 02/06/26 | 124.00 on 01/22/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 26,748,858 | 27,527,588 | 21,425,456 | ||
| Shares Outstanding, K | 576,857 | 146,759 | 251,325 | ||
| Annual Sales | 2,378,190,000 | 9,890,600,000 | 3,247,010,000 | ||
| Annual Net Income | 770,950,000 | 1,292,900,000 | -1,285,380,000 | ||
| Last Quarter Sales | 621,990,000 | 2,279,400,000 | 982,920,000 | ||
| Last Quarter Net Income | 214,210,000 | -48,900,000 | -374,920,000 | ||
| 60-Month Beta | 0.40 | 0.15 | 1.51 | ||
| Per-Share Information | |||||
| Most Recent Earnings | 1.46 on 02/11/26 | 1.99 on 02/06/26 | -0.38 on 03/10/26 | ||
| Latest Earnings Date | 05/14/26 | 05/07/26 | 05/04/26 | ||
| Most Recent Dividend | 0.235 on 02/20/26 | N/A | 3.084 on 06/02/22 | ||
| Next Ex-Dividends Date | 02/20/26 | N/A | 06/02/22 | ||
| Ratios | |||||
| Price/Earnings ttm | 9.60 | 12.02 | 0.00 | ||